TY  - JOUR
T1  - ADverse outcomes associated with use of proton pump inhibitors and clopidogrel—reply
AU  - Ho P, Rumsfeld JS, Wang L
Y1  - 2009/07/01
N1  - 10.1001/jama.2009.900
JO  - JAMA
SP  - 29
EP  - 31
VL  - 302
IS  - 1
N2  - 
Chae and Kim cite the ACCF/ACG/AHA consensus statement on reducing gastrointestinal risks of antiplatelet therapy and NSAID use. This statement recommended that patients taking dual antiplatelet therapy should be prescribed a PPI medication in the presence of specific risk factors.1

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.900
UR  - http://dx.doi.org/10.1001/jama.2009.900
ER  -